glp 1 r retatrutide Research Guide: What the Phase 2 Trial Data Reported (2026) Doctor Reveals The BEST GLP-1
Description
doi: 10.1371/journal.pone.0076941
doi: 10.1080/02699052.2019.1587000 [DOI] [PubMed] [Google Scholar] 21
Aharon-Hananel G, Cohen Y, Tau N
They lost about 8% of their body weight in 24 weeks
The medication showcased positive effects on glycemic parameters and cardiometabolic risk factors, with greater efficacy observed in obese patients
